The stock already discounts a lot of good news, so the upside case depends more on business compounding than on multiple expansion. I think Credo can keep a
premium valuation because its products sit in a mission-critical,
qualification-heavy layer of AI infrastructure, but that premium should compress somewhat as the company gets larger and competition broadens. That still leaves room for strong equity appreciation if
AEC leadership expands into optics, photonics and adjacent connectivity content.